Reference
Cuker A, et al. Immune thrombocytopenia in alemtuzumab-treated MS patients: Incidence, detection, and management. Multiple Sclerosis Journal 26: 48-56, No. 1, Jan 2020. Available from: URL: http://doi.org/10.1177/1352458518816612
Rights and permissions
About this article
Cite this article
Alemtuzumab. Reactions Weekly 1796, 19 (2020). https://doi.org/10.1007/s40278-020-76306-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-020-76306-1